Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Zhejiang Jiaao Enprotech Stock Co., Ltd (603822.SS)
Tongxiang, CN
Zhejiang Jiaao Enprotech Stock Co., Ltd is a company dedicated to the development, manufacturing, and global distribution of plasticizers. Its extensive product line includes epoxy, fossil-based, and advanced multifunctional composite plasticizers. These essential chemical compounds are widely utilized in diverse applications such as electrical cables, artificial leather, flocking processes, light box membranes, various plastic films and decking materials, and durable outdoor water pipes, among others. The firm was established in 2003 and operates from its headquarters in Tongxiang, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.11% | -1.31% | -2.01% | -32.31% | -7.67% | -21.83% | +54.41% | +140.68% | +239.32% | +51.86% | +345.54% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+279.3% ★ Q1'26: +18.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+108.6% ★ Q1'26: +4.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-6.2% Q1'26: -70.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+8.7% Q1'26: -4.8% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+9.5% ★ Q1'26: -1.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.4% ★ Q1'26: -0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×4.48× Q1'26: -48.42× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
1.92B
est: 2.03B (-5.5%)
|
3.21B
est: 3.09B (+3.9%)
|
2.67B
est: 3.25B (-17.9%)
|
1.27B
est: 3.83B (-66.8%)
|
4.83B
est: 5.30B (-8.9%)
|
7.25B
7.25B – 7.25B
+36.7% YoY
|
13.41B
13.41B – 13.41B
+85.0% YoY
|
| EBITDA |
207.16M
est: 59.98M (+245.4%)
|
48.48M
est: 91.42M (-47.0%)
|
151.90M
est: 96.03M (+58.2%)
|
-161.92M
est: 157.60M (-202.7%)
|
737.40M
est: 218.10M (+238.1%)
|
298.19M
298.19M – 298.19M
+36.7% YoY
|
551.55M
551.55M – 551.55M
+85.0% YoY
|
| EBIT |
145.85M
est: -39.18M (+472.3%)
|
-14.55M
est: -59.71M (+75.6%)
|
44.98M
est: -62.72M (+171.7%)
|
-303.99M
est: -48.54M (-526.3%)
|
419.80M
est: -67.17M (+725.0%)
|
-91.84M
-91.84M – -91.84M
-36.7% YoY
|
-169.86M
-169.86M – -169.86M
-85.0% YoY
|
| Net Income |
102.06M
est: 112.61M (-9.4%)
|
-32.44M
est: 111.07M (-129.2%)
|
-7.54M
est: 106.44M (-107.1%)
|
-366.94M
est: 209.67M (-275.0%)
|
31.35M
est: 257.29M (-87.8%)
|
540.68M
540.68M – 540.68M
+110.1% YoY
|
1.33B
1.33B – 1.33B
+146.0% YoY
|
| SGA |
91.90M
est: 35.02M (+162.4%)
|
99.57M
est: 53.38M (+86.5%)
|
90.98M
est: 56.07M (+62.3%)
|
127.30M
est: 174.93M (-27.2%)
|
73.69M
est: 242.09M (-69.6%)
|
330.99M
330.99M – 330.99M
+36.7% YoY
|
612.20M
612.20M – 612.20M
+85.0% YoY
|
| EPS |
1.39
est: 1.46 (-4.8%)
|
-0.44
est: 1.44 (-130.6%)
|
-0.10
est: 1.38 (-107.1%)
|
-4.76
est: 2.73 (-274.4%)
|
0.41
est: 3.35 (-87.8%)
|
7.04
7.04 – 7.04
+110.1% YoY
|
17.32
17.32 – 17.32
+146.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jian Shen | GM & Chairman of the Board | — | male |
| Jinfu Zhang | Deputy GM & Director | — | male |
| Xiao Huang | Head of Accounting | — | — |
| Xiaohong Ding | Chairman of the Supervisory Committee & Director of the Human Resources Department | — | female |
| Yantao Wang | Deputy GM & Director | — | female |
| Yimin Wu | Chief Financial Officer and Board Secretary | — | male |
| Yingchuan Shen | Deputy GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603822.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
